Back
ADDDB
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Adavale Resources Limited
๐ฆ๐บ ASX
๐ HIGH PRICE GROWTH
๐ Overview
๐ Performance
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
+ 14.44%
Annual Growth
5 years average annual capital growth
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
4
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Adavale Resources Limited
๐ Performance
Price History
+72.22%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$0.03
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in ADDDB
0
๐ Total Capital Earnings
N/A
๐ Average investment frequency
N/A
๐ต Average investment amount
N/A
โฐ Last time a customer invested in ADDDB
N/A
ADDDB investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
๐ Legal gender of investors
Female
Male
Pearlers who invest in ADDDB also invest in...
Adavale Resources Ltd. engages in the business of mineral exploration for nickel in Tanzania and uranium in South Australia. The company is headquartered in Leederville, Western Australia. The firm holds the Kabanga Jirani Nickel Project, a portfolio of 12 highly prospective granted licenses along the Karagwe-Ankolean belt in Tanzania. The nine southernmost licenses are proximal to the world-class Kabanga Nickel Deposit. The company holds 100% of all licenses except two licenses known as the Luhuma-Farm-in are held 65% adding a further 99 square kilometers (km2) bringing the portfolio to 1,315 sq km. The company also holds five granted exploration licences prospective for their sedimentary uranium potential within the northern part of the highly prospective Northern outwash from the Flinders Ranges in South Australia and four exploration licence applications east of Ceduna on the Eyre Peninsula. This will increase the Companyโs uranium tenement holdings to 5,160 km2. The firm also has a 100% interest in EL6553 from Kilonova Metals.
๐ Performance (5Yr p.a)
6.69%
๐ Share price
$0.04 AUD
โ๏ธ MINING
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
๐ Performance (5Yr p.a)
21.53%
๐ Share price
$68.13 AUD
๐ HIGH PRICE GROWTH
๐บ๐ธ UNITED STATES
Adavale Resources Ltd. engages in mining exploration and development of uranium properties. The company is headquartered in Leederville, Western Australia. The firm is in the business of mineral exploration for nickel in Tanzania and Uranium in South Australia. The firm's projects include Kabanga Jirani Nickel Project and Lake Surprise Uranium Project. The company holds 100% of the Kabanga Jirani Nickel Project, a portfolio of over 12 granted licenses covering approximately 1,216 square kilometers along the Karagwe-Ankolean belt in Tanzania. The seven southernmost licenses are proximal to the Kabanga Nickel Deposit. The company has farmed-in to two more licenses contiguous to its four southernmost licenses, adding approximately 99 square kilometers to the portfolio (Luhuma Nickel Project). The Lake Surprise Project area is located in South Australia, approximately 550 kilometers (km) north of Adelaide, and 70 km east of Marree. The firm holds four tenements, such as EL5892, EL5893, EL 6821 and EL6598, with a total area of approximately 1,078 square kilometers.
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The firm is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimerโs Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamemโs mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamemโs therapeutic potential.
๐ Performance (5Yr p.a)
2.59%
๐ Share price
$0.03 AUD
๐งฌ BIOTECHNOLOGY
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
๐ Performance (5Yr p.a)
19.90%
๐ Share price
$56.02 AUD
๐ HIGH PRICE GROWTH
๐ค TECHNOLOGY
๐บ๐ธ UNITED STATES
Want more shares? Try these...